Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease

NCT01604213 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Ischemic Heart Disease

Interventions

DRUG: Metformin plus vildagliptin
DRUG: Metformin only

Sponsor

Sheba Medical Center